Bullboard - Stock Discussion Forum Mind Medicine (MindMed) Inc N.MMED.WA

Primary Symbol: MNMD Alternate Symbol(s): N.MMED.WS | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

Add To Watchlist

NDAQ:MNMD - Post Discussion

Mind Medicine (MindMed) Inc > Q1 Earnings Release _ HOLL_ Easy money over the next 6 month

View:

Post by Catmando123 on Jun 01, 2021 1:26pm

Q1 Earnings Release _ HOLL_ Easy money over the next 6 month

First quarter revenue was USD $23.1 million compared to USD $0.95 million in the first quarter of 2020 and up 97% sequentially from USD $11.7 million in the fourth quarter of 2020
First quarter net income was USD $2.0 million compared to a net loss of USD $2.2 million in the first quarter of 2020
Adjusted EBITDA was USD $2.80 million in the first quarter compared to a loss of USD $1.1 million in the first quarter of 2020

VANCOUVER, BC, June 1, 2021 /CNW/ - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 95 dispensaries throughout Arizona, today reported its financial and operating results for the first quarter of 2021. All financial information is presented in U.S. dollars unless otherwise indicated.